Skip to content
Alembic Pharma obtains final approval from Usfda for generic Doryx tablets

 |  Latest News Headlines

Alembic Pharma obtains final approval from Usfda for generic Doryx tablets

| Today Headlines | Local News


Alembic Pharma is the center of attention as the company has obtained final approval from the United States Food & Drug Administration (USFDA) for doxycycline hyclate delayed-release tablets. It is a drug which is used to treat bacteria resistant to drugs. Their market size is quite small, so it’s around $ 10 million in terms of total market size, but nonetheless, it adds to their kitty in terms of approvals when it comes to US markets.

Watch CNBC-TV18’s Ekta Batra companion video for more details.

First publication: STI

Alembic Pharma obtains final approval from Usfda for generic Doryx tablets

| Breaking News Updates Local news
cnbctv18-forexlive-benzinga

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.